U.S. Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pedi

U.S. Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028

The U.S. clinical nutrition market is expected to witness exponential growth through 2028 on account of rising health consciousness among consumers in the region.

Recently, industry players have been adopting profitable strategies to extend their consumer reach, which has been favorable for business growth. For instance, in February 2022, Nestlé Health Science, an American clinical nutrition expert, completed the acquisition of Vital Proteins, a leading specialist in collagen in the U.S. and a major provider of beverages, supplements, and food products. With the takeover, Nestlé intended to expand its brand geographically, focus on product innovation, and scale up R&D activities, while capitalizing on proliferating consumer interest in collagen.

The U.S. clinical nutrition market has been bifurcated in terms of product, consumer, application, and distribution channel. Based on product, the market has further been segregated into enteral nutrition, infant nutrition, and parenteral nutrition. The infant nutrition sub-segment is expected to reach more than USD 11,183 million in revenue by 2028, growing at a steady CAGR over the study timeframe. Increasing premature birth and rising birth rate in the U.S. is slated to foster segmental outlook in the forthcoming years.

On the basis of consumer, the U.S. clinical nutrition market has been segmented into adult and pediatric. In 2021, the pediatric sub-segment accounted for a major market share and is anticipated to experience notable growth over the analysis timeframe to be valued at over USD 11,907 million by the end of 2028. Mounting patient population suffering from numerous chronic and cardiovascular diseases in the U.S. is likely to drive segmental demand in the coming years.

By application, the U.S. clinical nutrition market has been divided into metabolic disorders, cancer, gastrointestinal disorders, neurological diseases, and others. The metabolic disorders sub-segment accounted for a notable market share in 2021 and is projected to progress at a solid pace to garner a revenue of about USD 6,377 million by 2028. Rising prevalence of numerous types of metabolic disorders among the geriatric population in the country is set to bolster segmental development in the future.

From the distribution channel perspective, the U.S. clinical nutrition market has been classified into retail stores, online channels, pharmacies & drug stores, and others. In 2021, the retail stores sub-segment held a considerable share in the market and is primed to witness healthy growth through the forecast timespan to attain a valuation of above USD 8,334 million by 2028. Soaring adoption and easy accessibility of clinical nutrition products in the country are foreseen to promote the growth of the segment over the following years.